Oct 5Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine StudyInvestor's Business Daily
Sep 29AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, MerckInvestor's Business Daily

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.

Next results expected Nov 3, 2026 (Q3 2026). Dates can move until the company confirms them.

From the company, last 60 days

No official announcements

No 8-K filed in the last 60 days.

In the press, last 3 weeks

Oct 5Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine StudyInvestor's Business Daily
Sep 29AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, MerckInvestor's Business Daily

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.